Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

NCT00536874 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin
GENETIC: protein expression analysis
GENETIC: proteomic profiling
OTHER: diagnostic laboratory biomarker analysis
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]